Claro Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-5,627
| Closed | -$234K | – | 539 |
|
2024
Q4 | $234K | Sell |
5,627
-1,184
| -17% | -$49.2K | 0.03% | 422 |
|
2024
Q3 | $455K | Buy |
6,811
+1,265
| +23% | +$84.5K | 0.06% | 280 |
|
2024
Q2 | $659K | Buy |
5,546
+108
| +2% | +$12.8K | 0.1% | 201 |
|
2024
Q1 | $579K | Sell |
5,438
-174
| -3% | -$18.5K | 0.1% | 211 |
|
2023
Q4 | $558K | Buy |
5,612
+3,333
| +146% | +$331K | 0.12% | 190 |
|
2023
Q3 | $235K | Buy |
2,279
+315
| +16% | +$32.5K | 0.06% | 317 |
|
2023
Q2 | $239K | Sell |
1,964
-36
| -2% | -$4.37K | 0.06% | 309 |
|
2023
Q1 | $307K | Sell |
2,000
-117
| -6% | -$18K | 0.09% | 247 |
|
2022
Q4 | $380K | Sell |
2,117
-236
| -10% | -$42.4K | 0.12% | 201 |
|
2022
Q3 | $336K | Hold |
2,353
| – | – | 0.13% | 180 |
|
2022
Q2 | $336K | Sell |
2,353
-316
| -12% | -$45.1K | 0.13% | 180 |
|
2022
Q1 | $678K | Hold |
2,669
| – | – | 0.24% | 106 |
|
2021
Q4 | $678K | Buy |
2,669
+174
| +7% | +$44.2K | 0.24% | 106 |
|
2021
Q3 | $960K | Buy |
2,495
+338
| +16% | +$130K | 0.4% | 63 |
|
2021
Q2 | $507K | Sell |
2,157
-706
| -25% | -$166K | 0.23% | 125 |
|
2021
Q1 | $375K | Buy |
2,863
+587
| +26% | +$76.9K | 0.19% | 138 |
|
2020
Q4 | $238K | Sell |
2,276
-2,444
| -52% | -$256K | 0.13% | 179 |
|
2020
Q3 | $334K | Buy |
+4,720
| New | +$334K | 0.21% | 130 |
|